Publications by authors named "Arancha Cebrian"

Claim this Profile
A
Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer.
Anxo Rio-Vilariño, Ana Garcia-Bautista, Aiora Cenigaonandia-Campillo, Pedro A Mateos-Gomez, Laura Garcia-Garcia, Arancha Cebrian

Mol Ther Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
POLQ immunostaining behaves as a prognostic factor for pancreatic carcinoma.
Laura Del Puerto-Nevado, María J Fernández-Aceñero, Arancha Cebrián, Yuliia Fatych, Luis I Díez-Valladares

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin-C-dependent downregulation of the citrate metabolism pathway potentiates pancreatic ductal adenocarcinoma growth arrest.
Aiora Cenigaonandia-Campillo, Ana Garcia-Bautista, Anxo Rio-Vilariño, Arancha Cebrian, Laura Del Puerto

Mol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Dr. Rafael Rosell: Shedding some light on the unresolved issue of YAP1 Ser397 phosphorylation in cancer.
Anxo Río-Vilariño, Jesús García-Foncillas, Arancha Cebrián

Br J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Anxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer

Br J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Anxo Rio-Vilariño, Aiora Cenigaonandia-Campillo, Ana García-Bautista, Pedro A Mateos-Gómez, Marina I Schlaepfer

Br J Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
Juan Manuel Corral, Laura Del Puerto-Nevado, Mabel Cedeño, Anxo Río-Vilariño, Ignacio Mahillo-Fernández

Biomed Pharmacother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells.
Juan Carlos Lacal, Rosario Perona, Javier de Castro, Arancha Cebrián

Pharmaceutics· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer.
Sonia Solanes-Casado, Arancha Cebrián, María Rodríguez-Remírez, Ignacio Mahíllo, Laura García-García

Biomed Pharmacother· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas.
María Rodríguez-Remírez, Laura Del Puerto-Nevado, María Jesús Fernández-Aceñero, Marlid Cruz-Ramos, Laura García-García

Neuroendocrinology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance.
Anxo Rio-Vilariño, Laura Del Puerto-Nevado, Jesús García-Foncillas, Arancha Cebrián

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study.
María Rodríguez-Remírez, Laura Del Puerto-Nevado, María Jesús Fernández Aceñero, Hakimeh Ebrahimi-Nik, Marlid Cruz-Ramos

Neuroendocrinology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
Marlid Cruz-Ramos, Laura Del Puerto-Nevado, Binbin Zheng, Rafael López-Bajo, Arancha Cebrian

J Geriatr Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
Javier Martinez-Useros, Tihomir Georgiev-Hristov, María Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Alberto Indacochea

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.
Arancha Cebrián, Teresa Gómez Del Pulgar, María José Méndez-Vidal, María Luisa Gonzálvez, Nuria Lainez

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Arancha Cebrián, Teresa Gómez Del Pulgar, Maria Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Laura Del Puerto-Nevado

Pathol Res Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer.
Teresa Gómez Del Pulgar, Arancha Cebrián, Maria Jesús Fernández-Aceñero, Aurea Borrero-Palacios, Laura Del Puerto-Nevado

J Cell Mol Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study.
Laura Del Puerto-Nevado, Juan Pablo Marin-Arango, Maria Jesus Fernandez-Aceñero, David Arroyo-Manzano, Javier Martinez-Useros, Arancha Cebrian

BMC Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Javier Martinez-Useros, Maria Rodriguez-Remirez, Aurea Borrero-Palacios, Irene Moreno, Arancha Cebrian

BMC Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
Ana de la Cueva, Ana Ramírez de Molina, Néstor Alvarez-Ayerza, Ma Angeles Ramos, Arancha Cebrián

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiplasmodial activity and mechanism of action of RSM-932A, a promising synergistic inhibitor of Plasmodium falciparum choline kinase.
Tahl Zimmerman, Carlos Moneriz, Amalia Diez, José Manuel Bautista, Teresa Gómez Del Pulgar

Antimicrob Agents Chemother· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics.
Juan Casado-Vela, Arancha Cebrián, María Teresa Gómez del Pulgar, Juan Carlos Lacal

Clin Transl Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.
David Gallego-Ortega, Teresa Gómez del Pulgar, Fátima Valdés-Mora, Arancha Cebrián, Juan Carlos Lacal

Adv Enzyme Regul· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human urine proteomics: building a list of human urine cancer biomarkers.
Juan Casado-Vela, Teresa Gómez del Pulgar, Arancha Cebrián, Nestor Alvarez-Ayerza, Juan Carlos Lacal

Expert Rev Proteomics· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lights and shadows of proteomic technologies for the study of protein species including isoforms, splicing variants and protein post-translational modifications.
Juan Casado-Vela, Arancha Cebrián, Maria Teresa Gómez del Pulgar, Elsa Sánchez-López, Marta Vilaseca

Proteomics· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis